Annual Current Assets
$94.33 M
-$206.00 M-68.59%
31 December 2023
Summary:
Sangamo Therapeutics annual total current assets is currently $94.33 million, with the most recent change of -$206.00 million (-68.59%) on 31 December 2023. During the last 3 years, it has fallen by -$565.34 million (-85.70%). SGMO annual current assets is now -85.70% below its all-time high of $659.67 million, reached on 31 December 2020.SGMO Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$58.13 M
+$18.06 M+45.06%
30 September 2024
Summary:
Sangamo Therapeutics quarterly total current assets is currently $58.13 million, with the most recent change of +$18.06 million (+45.06%) on 30 September 2024. Over the past year, it has dropped by -$89.44 million (-60.61%). SGMO quarterly current assets is now -91.70% below its all-time high of $700.29 million, reached on 30 September 2020.SGMO Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGMO Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -68.6% | -60.6% |
| 3 y3 years | -85.7% | -87.0% |
| 5 y5 years | -77.0% | -84.9% |
SGMO Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -85.7% | at low | -87.0% | +45.1% |
| 5 y | 5 years | -85.7% | at low | -91.7% | +45.1% |
| alltime | all time | -85.7% | +1050.3% | -91.7% | +165.1% |
Sangamo Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $58.13 M(+45.1%) |
| June 2024 | - | $40.08 M(-41.6%) |
| Mar 2024 | - | $68.64 M(-27.2%) |
| Dec 2023 | $70.99 M(-72.9%) | $94.33 M(-36.1%) |
| Sept 2023 | - | $147.58 M(-7.5%) |
| June 2023 | - | $159.61 M(-29.7%) |
| Mar 2023 | - | $227.09 M(-24.4%) |
| Dec 2022 | $262.18 M(-18.9%) | $300.33 M(-10.8%) |
| Sept 2022 | - | $336.62 M(-1.9%) |
| June 2022 | - | $343.12 M(+0.9%) |
| Mar 2022 | - | $340.06 M(-14.7%) |
| Dec 2021 | $323.15 M(+15.9%) | $398.77 M(-10.9%) |
| Sept 2021 | - | $447.40 M(-19.3%) |
| June 2021 | - | $554.06 M(-8.7%) |
| Mar 2021 | - | $606.94 M(-8.0%) |
| Dec 2020 | $278.88 M(+20.2%) | $659.67 M(-5.8%) |
| Sept 2020 | - | $700.29 M(+3.1%) |
| June 2020 | - | $679.40 M(+83.2%) |
| Mar 2020 | - | $370.95 M(-8.5%) |
| Dec 2019 | $232.04 M(+29.0%) | $405.47 M(+5.5%) |
| Sept 2019 | - | $384.18 M(-16.8%) |
| June 2019 | - | $461.81 M(+27.4%) |
| Mar 2019 | - | $362.63 M(-11.7%) |
| Dec 2018 | $179.87 M(+369.1%) | $410.52 M(-12.3%) |
| Sept 2018 | - | $468.20 M(-14.9%) |
| June 2018 | - | $550.05 M(+132.8%) |
| Mar 2018 | - | $236.28 M(-4.9%) |
| Dec 2017 | $38.34 M(+361.4%) | $248.40 M(+2.5%) |
| Sept 2017 | - | $242.34 M(-5.2%) |
| June 2017 | - | $255.68 M(+91.1%) |
| Mar 2017 | - | $133.77 M(-10.6%) |
| Dec 2016 | $8.31 M(+78.6%) | $149.58 M(+0.5%) |
| Sept 2016 | - | $148.84 M(-15.5%) |
| June 2016 | - | $176.15 M(-7.8%) |
| Mar 2016 | - | $191.14 M(-10.1%) |
| Dec 2015 | $4.65 M(-91.1%) | $212.58 M(-6.6%) |
| Sept 2015 | - | $227.68 M(+3.0%) |
| June 2015 | - | $221.00 M(+8.4%) |
| Mar 2015 | - | $203.95 M(+6.8%) |
| Dec 2014 | $52.33 M(+20.1%) | $190.88 M(+10.2%) |
| Sept 2014 | - | $173.17 M(-14.7%) |
| June 2014 | - | $202.98 M(-7.8%) |
| Mar 2014 | - | $220.21 M(+126.4%) |
| Dec 2013 | $43.56 M(+207.5%) | $97.27 M(-22.9%) |
| Sept 2013 | - | $126.14 M(+134.8%) |
| June 2013 | - | $53.72 M(-12.7%) |
| Mar 2013 | - | $61.55 M(-10.0%) |
| Dec 2012 | $14.17 M | $68.36 M(+9.6%) |
| Sept 2012 | - | $62.39 M(-2.0%) |
| June 2012 | - | $63.66 M(-22.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $81.82 M(-4.5%) |
| Dec 2011 | $1.64 M(-2.4%) | $85.69 M(-1.2%) |
| Sept 2011 | - | $86.70 M(-7.8%) |
| June 2011 | - | $94.03 M(+96.3%) |
| Mar 2011 | - | $47.89 M(-21.9%) |
| Dec 2010 | $1.69 M(+1.1%) | $61.31 M(-4.3%) |
| Sept 2010 | - | $64.09 M(-8.7%) |
| June 2010 | - | $70.23 M(-9.3%) |
| Mar 2010 | - | $77.46 M(-9.7%) |
| Dec 2009 | $1.67 M(-16.6%) | $85.77 M(+72.6%) |
| Sept 2009 | - | $49.69 M(-6.5%) |
| June 2009 | - | $53.13 M(-9.9%) |
| Mar 2009 | - | $58.97 M(-10.5%) |
| Dec 2008 | $2.00 M(+12.1%) | $65.85 M(-4.1%) |
| Sept 2008 | - | $68.63 M(-7.1%) |
| June 2008 | - | $73.86 M(-1.1%) |
| Mar 2008 | - | $74.71 M(-9.0%) |
| Dec 2007 | $1.78 M(+146.1%) | $82.12 M(-3.4%) |
| Sept 2007 | - | $84.99 M(+85.8%) |
| June 2007 | - | $45.75 M(-8.0%) |
| Mar 2007 | - | $49.75 M(-9.6%) |
| Dec 2006 | $724.00 K(+39.0%) | $55.06 M(-4.7%) |
| Sept 2006 | - | $57.77 M(-4.1%) |
| June 2006 | - | $60.23 M(+38.9%) |
| Mar 2006 | - | $43.36 M(-10.5%) |
| Dec 2005 | $521.00 K(+49.3%) | $48.46 M(+99.6%) |
| Sept 2005 | - | $24.27 M(-9.9%) |
| June 2005 | - | $26.93 M(-11.8%) |
| Mar 2005 | - | $30.52 M(-11.2%) |
| Dec 2004 | $349.00 K(-63.1%) | $34.38 M(-4.3%) |
| Sept 2004 | - | $35.94 M(-9.7%) |
| June 2004 | - | $39.80 M(-6.4%) |
| Mar 2004 | - | $42.49 M(-6.2%) |
| Dec 2003 | $947.00 K(-55.6%) | $45.28 M(-3.6%) |
| Sept 2003 | - | $46.96 M(-3.6%) |
| June 2003 | - | $48.70 M(-4.2%) |
| Mar 2003 | - | $50.81 M(-6.1%) |
| Dec 2002 | $2.13 M(-90.0%) | $54.10 M(+0.8%) |
| Sept 2002 | - | $53.67 M(-4.7%) |
| June 2002 | - | $56.34 M(-5.8%) |
| Mar 2002 | - | $59.80 M(-6.2%) |
| Dec 2001 | $21.25 M(+780.5%) | $63.77 M(-2.5%) |
| Sept 2001 | - | $65.39 M(+4.6%) |
| June 2001 | - | $62.51 M(-4.1%) |
| Mar 2001 | - | $65.21 M(-2.0%) |
| Dec 2000 | $2.41 M(+141.3%) | $66.51 M(+33.2%) |
| Sept 2000 | - | $49.94 M(-11.3%) |
| June 2000 | - | $56.28 M(+156.7%) |
| Mar 2000 | - | $21.93 M |
| Dec 1999 | $1.00 M | - |
FAQ
- What is Sangamo Therapeutics annual total current assets?
- What is the all time high annual current assets for Sangamo Therapeutics?
- What is Sangamo Therapeutics annual current assets year-on-year change?
- What is Sangamo Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Sangamo Therapeutics?
- What is Sangamo Therapeutics quarterly current assets year-on-year change?
What is Sangamo Therapeutics annual total current assets?
The current annual current assets of SGMO is $94.33 M
What is the all time high annual current assets for Sangamo Therapeutics?
Sangamo Therapeutics all-time high annual total current assets is $659.67 M
What is Sangamo Therapeutics annual current assets year-on-year change?
Over the past year, SGMO annual total current assets has changed by -$206.00 M (-68.59%)
What is Sangamo Therapeutics quarterly total current assets?
The current quarterly current assets of SGMO is $58.13 M
What is the all time high quarterly current assets for Sangamo Therapeutics?
Sangamo Therapeutics all-time high quarterly total current assets is $700.29 M
What is Sangamo Therapeutics quarterly current assets year-on-year change?
Over the past year, SGMO quarterly total current assets has changed by -$89.44 M (-60.61%)